High efficacy of interferon-free therapy for acute hepatitis C in HIV-positive patients.
David ChromyMattias MandorferTheresa BucsicsPhilipp SchwablBernhard ScheinerCaroline SchmidbauerMaximilian Christopher AichelburgPeter FerenciMichael TraunerMarkus Peck-RadosavljevicThomas ReibergerPublished in: United European gastroenterology journal (2019)
Interferon-free DAA regimens (including 34% pan-genotypic regimens) yielded 100% SVR12 in HIV/AHC individuals if treatment durations similar to CHC are applied.
Keyphrases
- hiv positive
- antiretroviral therapy
- men who have sex with men
- south africa
- end stage renal disease
- human immunodeficiency virus
- hiv testing
- hiv infected
- ejection fraction
- dendritic cells
- chronic kidney disease
- liver failure
- prognostic factors
- hiv aids
- hepatitis c virus
- patient reported outcomes
- intensive care unit
- hepatitis b virus
- acute respiratory distress syndrome
- replacement therapy
- smoking cessation